Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/35710
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorROEH, Astrid
dc.contributor.authorMALCHOW, Berend
dc.contributor.authorLEVOLD, Katrin
dc.contributor.authorLABUSGA, Marcin
dc.contributor.authorKELLER-VARADY, Katriona
dc.contributor.authorSCHNEIDER-AXMANN, Thomas
dc.contributor.authorWOBROCK, Thomas
dc.contributor.authorSCHMITT, Andrea
dc.contributor.authorFALKAI, Peter
dc.contributor.authorHASAN, Alkomiet
dc.date.accessioned2020-03-24T15:02:51Z-
dc.date.available2020-03-24T15:02:51Z-
dc.date.issued2020
dc.identifier.citationNEUROPSYCHOBIOLOGY, v.79, n.1, p.100-107, 2020
dc.identifier.issn0302-282X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35710-
dc.description.abstractBackground: Aerobic endurance training has been discussed to induce brain plasticity and improve cognitive functions in healthy subjects and patients with neuropsychiatric disorders. For schizophrenia, a motor cortical inhibitory deficit has been established as one aspect of impaired plasticity, especially involving impairments in GABAergic interneuron networks, but the possibility to restore these deficits via exercise-induced plasticity has not been evaluated yet. Methods: 17 schizophrenia patients and 16 matched healthy controls underwent 3 months of aerobic endurance training (30 min, 3 times a week) on bicycle ergometers. After 6 weeks, computer-assisted cognitive remediation training (30 min, 2 times a week) was added. Transcranial magnetic stimulation of the left and right hemispheres was performed at baseline and at the end of the intervention. We evaluated the intensity to induce a motor-evoked potential of 1 mV (S1mV), the resting motor threshold (RMT), the cortical silent period (CSP) at an intensity of 120 and 150% of the individual RMT, short-latency interval intracortical inhibition (3 ms), and intracortical facilitation (7 and 15 ms). Depending on the variable and hemisphere, follow-up data was available for 7-15 schizophrenia patients and for 10-12 healthy controls. Results: Repeated measures ANOVA revealed no significant time x group interactions for any of the analyzed variables. A significant increase in S1mV and CSP duration at 150% RMT of the left hemisphere could be observed in both groups over time. Conclusion: Regular ergometer training over 3 months increases motor cortical inhibition as displayed by an increase in CSP. The increase in S1mV may also indicate a higher degree of inhibition after the intervention. We could not establish a difference between schizophrenia patients and healthy controls. Due to the limited sample size, our results have to be considered as preliminary and need to be replicated in future trials.eng
dc.language.isoeng
dc.publisherKARGEReng
dc.relation.ispartofNeuropsychobiology
dc.rightsrestrictedAccesseng
dc.subjectEndurance trainingeng
dc.subjectSchizophreniaeng
dc.subjectMotor cortical excitabilityeng
dc.subjectTranscranial magnetic stimulationeng
dc.subject.othertranscranial magnetic stimulationeng
dc.subject.otherinhibitioneng
dc.subject.otherexerciseeng
dc.subject.otherplasticityeng
dc.titleEffects of Three Months of Aerobic Endurance Training on Motor Cortical Excitability in Schizophrenia Patients and Healthy Subjectseng
dc.typearticleeng
dc.rights.holderCopyright KARGEReng
dc.identifier.doi10.1159/000489714
dc.identifier.pmid30001538
dc.subject.wosNeuroscienceseng
dc.subject.wosPsychiatryeng
dc.subject.wosPsychologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalROEH, Astrid:Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Munich, Germany
hcfmusp.author.externalMALCHOW, Berend:Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany
hcfmusp.author.externalLEVOLD, Katrin:Georg August Univ, Dept Psychiat & Psychotherapy, Gottingen, Germany
hcfmusp.author.externalLABUSGA, Marcin:Georg August Univ, Dept Psychiat & Psychotherapy, Gottingen, Germany
hcfmusp.author.externalKELLER-VARADY, Katriona:Hannover Med Sch, Inst Sports Med, Hannover, Germany
hcfmusp.author.externalSCHNEIDER-AXMANN, Thomas:Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Munich, Germany
hcfmusp.author.externalWOBROCK, Thomas:Georg August Univ, Dept Psychiat & Psychotherapy, Gottingen, Germany; Cty Hosp Darmstadt Dieburg, Dept Psychiat & Psychotherapy, Gross Umstadt, Gross Umstadt, Germany
hcfmusp.author.externalFALKAI, Peter:Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Munich, Germany
hcfmusp.author.externalHASAN, Alkomiet:Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Munich, Germany
hcfmusp.description.beginpage100
hcfmusp.description.endpage107
hcfmusp.description.issue1
hcfmusp.description.volume79
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000510871600010
hcfmusp.origem.id2-s2.0-85049899668
hcfmusp.publisher.cityBASELeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceBenes FM, 2015, SCHIZOPHR RES, V167, P1, DOI 10.1016/j.schres.2015.07.017eng
hcfmusp.relation.referenceBunse T, 2014, BRAIN STIMUL, V7, P158, DOI 10.1016/j.brs.2013.08.009eng
hcfmusp.relation.referenceCirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834eng
hcfmusp.relation.referenceDai W, 2016, NEUROSCIENCE, V336, P114, DOI 10.1016/j.neuroscience.2016.08.053eng
hcfmusp.relation.referenceDaskalakis ZJ, 2003, PSYCHOPHARMACOLOGY, V170, P255, DOI 10.1007/s00213-003-1548-1eng
hcfmusp.relation.referenceFalkai P, 2015, MOL PSYCHIATR, V20, P671, DOI 10.1038/mp.2015.35eng
hcfmusp.relation.referenceFirth J, 2018, NEUROIMAGE, V166, P230, DOI 10.1016/j.neuroimage.2017.11.007eng
hcfmusp.relation.referenceFirth J, 2017, SCHIZOPHRENIA BULL, V43, P546, DOI 10.1093/schbul/sbw115eng
hcfmusp.relation.referenceFrantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151eng
hcfmusp.relation.referenceHasan A, 2013, EUR ARCH PSY CLIN N, V263, P621, DOI 10.1007/s00406-013-0446-8eng
hcfmusp.relation.referenceHasan A, 2012, BRAIN STIMUL, V5, P475, DOI 10.1016/j.brs.2011.08.004eng
hcfmusp.relation.referenceKeller-Varady K, 2018, SCHIZOPHR RES, V192, P64, DOI 10.1016/j.schres.2017.06.008eng
hcfmusp.relation.referenceKeller-Varady K, 2016, EUR ARCH PSY CLIN N, V266, P461, DOI 10.1007/s00406-015-0651-8eng
hcfmusp.relation.referenceKenney W. L., 2011, PHYSL SPORT EXERCISEeng
hcfmusp.relation.referenceKojima S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-43eng
hcfmusp.relation.referenceKUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912eng
hcfmusp.relation.referenceMalchow B, 2016, SCHIZOPHR RES, V173, P182, DOI 10.1016/j.schres.2015.01.005eng
hcfmusp.relation.referenceMalchow B, 2015, SCHIZOPHRENIA BULL, V41, P847, DOI 10.1093/schbul/sbv020eng
hcfmusp.relation.referenceMalchow B, 2013, EUR ARCH PSY CLIN N, V263, P451, DOI 10.1007/s00406-013-0423-2eng
hcfmusp.relation.referenceMoll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77.abseng
hcfmusp.relation.referenceMoscatelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155998eng
hcfmusp.relation.referenceOrth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025eng
hcfmusp.relation.referenceOxley T, 2004, BIOL PSYCHIAT, V56, P628, DOI 10.1016/j.biopsych.2004.08.023eng
hcfmusp.relation.referencePajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193eng
hcfmusp.relation.referenceRadhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014eng
hcfmusp.relation.referenceRidding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169eng
hcfmusp.relation.referenceRosenbaum S, 2014, J CLIN PSYCHIAT, V75, P964, DOI 10.4088/JCP.13r08765eng
hcfmusp.relation.referenceSarter M, 2005, SCHIZOPHRENIA BULL, V31, P117, DOI 10.1093/schbul/sbi006eng
hcfmusp.relation.referenceSheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whieng
hcfmusp.relation.referenceTerao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006eng
hcfmusp.relation.referenceVoss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001eng
hcfmusp.relation.referenceWobrock T, 2009, PHARMACOPSYCHIATRY, V42, P194, DOI 10.1055/s-0029-1224137eng
hcfmusp.relation.referenceZiemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1423-0224
hcfmusp.citation.scopus3-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/27
LIM/27 - Laboratório de Neurociências


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.